Shuttle Pharmaceuticals ( NASDAQ: SHPH ) received formal notice from Nasdaq that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2024. The Nasdaq notice has no immediate effect on the listing of the company’s common stock on the Nasdaq Capital Market. Source: Press Release More on Shuttle Pharmaceuticals Financial information for Shuttle Pharmaceuticals.